[1] |
Chandran V, Schentag CT, Gladman DD. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis[J]. Arthritis Rheum, 2007, 57(8): 1560⁃1563. DOI: 10.1002/art.23104.
|
[2] |
Khraishi M, Mong J, Mugford G, et al. The electronic Psoriasis and Arthritis Screening Questionnaire (ePASQ): a sensitive and specific tool to diagnose psoriatic arthritis patients[J]. J Cutan Med Surg, 2011, 15(3): 143⁃149.
|
[3] |
Ibrahim GH, Buch MH, Lawson C, et al. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire[J]. Clin Exp Rheumatol, 2009, 27(3): 469⁃474.
|
[4] |
Gladman DD, Schentag CT, Tom BD, et al: Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS)[J]. Ann Rheum Dis, 2009, 68(4): 497⁃501.DOI: 10.1136/ard.2008. 089441.
|
[5] |
Moll JM, Wright V. Psoriatic arthritis[J]. Semin Arthritis Rheum, 1973, 3(1): 55⁃78.
|
[6] |
Boehncke WH, Qureshi A, Merola JF, et al. Diagnosing and treating psoriatic arthritis: an update[J]. Br J Dermatol, 2014, 170(4): 772⁃786. DOI: 10.1111/bjd.12748.
|
[7] |
Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome[J]. Ann Rheum Dis, 2005, 64 Suppl 2: ii14⁃17. DOI: 10.1136/ard.2004. 032482.
|
[8] |
Chandran V, Raychaudhuri SP. Geoepidemiology and environ⁃mental factors of psoriasis and psoriatic arthritis[J]. J Autoimmun, 2010, 34(3): J314⁃321. DOI: 10.1016/j.jaut.2009. 12.001.
|
[9] |
全国银屑病流行调查组.全国1984年银屑病流行调查报告[J]. 中华皮肤科杂志, 1986, 19(5): 253⁃261.
|
|
National psoriaticepidemiological investigation group. National epidemiological investigation of psoriasisin 1984[J]. Chin J Dermatol, 1986, 19(5):253⁃261.
|
[10] |
Maldonado Ficco H, Citera G, Maldonado Cocco JA. Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria[J]. Clin Rheumatol, 2014, 33(2): 243⁃246. DOI: 10.1007/s10067⁃013⁃2412⁃2.
|
[11] |
Radtke MA, Reich K, Blome C, et al. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey[J]. J Eur Acad Dermatol Venereol, 2009, 23(6): 683⁃691. DOI: 10.1111/j.1468⁃3083.2009.03159.x.
|
[12] |
Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheuma⁃tologist⁃diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics[J]. J Am Acad Dermatol, 2013, 69(5): 729⁃735. DOI: 10.1016/j.jaad.2013.07. 023.
|
[13] |
Gladman DD, Shuckett R, Russell ML, et al. Psoriatic arthritis (PSA): an analysis of 220 patients[J]. Q J Med, 1987, 62(238): 127⁃141.
|
[14] |
Chandran V, Barrett J, Schentag CT, et al. Axial psoriatic arthritis: update on a longterm prospective study[J]. J Rheumatol, 2009, 36(12): 2744⁃2750. DOI: 10.3899/jrheum.090412.
|
[15] |
Raposo I,Torres T. Nail psoriasis as a predictor of the develop⁃ment of psoriatic arthritis[J]. Actas Dermosifiliogr, 2015, 106(6): 452⁃457. DOI: 10.1016/j.ad.2015.02.005.
|
[16] |
Wilson FC, Icen M, Crowson CS, et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population⁃based study[J]. Arthritis Rheum, 2009, 61(2): 233⁃239. DOI: 10.1002/art.24172.
|
[17] |
Liu JT, Yeh HM, Liu SY, et al. Psoriatic arthritis: epidemiology, diagnosis, and treatment[J]. World J Orthop, 2014, 5(4): 537⁃543. DOI: 10.5312/wjo.v5.i4.537.
|